About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Brachytherapy Market Size, Share & Top Companies Analysis by 2032
Brachytherapy Market Size, Share, Future Trends And Growth Analysis 2024-2032

Brachytherapy Market Size, Share & Trends Analysis Report By Dosage (High-dose Rate (HDR) Brachytherapy, Low-dose Rate (LDR) Brachytherapy), By Product (Seeds, Applicators & Afterloaders, Electronic Brachytherapy), By Applications (Prostate Cancer, Gynecological Cancer, Breast Cancer, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI56449DR
Last Updated : October 07, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Brachytherapy Market Introduction
    2. By Dosage
      1. Introduction
        1. Dosage By Value
      2. High-dose Rate (HDR) Brachytherapy
        1. By Value
      3. Low-dose Rate (LDR) Brachytherapy
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Seeds
        1. By Value
      3. Applicators & Afterloaders
        1. By Value
      4. Electronic Brachytherapy
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Prostate Cancer
        1. By Value
      3. Gynecological Cancer
        1. By Value
      4. Breast Cancer
        1. By Value
      5. Others
        1. By Value
    1. Introduction
    2. By Dosage
      1. Introduction
        1. Dosage By Value
      2. High-dose Rate (HDR) Brachytherapy
        1. By Value
      3. Low-dose Rate (LDR) Brachytherapy
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Seeds
        1. By Value
      3. Applicators & Afterloaders
        1. By Value
      4. Electronic Brachytherapy
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Prostate Cancer
        1. By Value
      3. Gynecological Cancer
        1. By Value
      4. Breast Cancer
        1. By Value
      5. Others
        1. By Value
    5. U.S.
      1. By Dosage
        1. Introduction
          1. Dosage By Value
        2. High-dose Rate (HDR) Brachytherapy
          1. By Value
        3. Low-dose Rate (LDR) Brachytherapy
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Seeds
          1. By Value
        3. Applicators & Afterloaders
          1. By Value
        4. Electronic Brachytherapy
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Prostate Cancer
          1. By Value
        3. Gynecological Cancer
          1. By Value
        4. Breast Cancer
          1. By Value
        5. Others
          1. By Value
    6. Canada
    1. Introduction
    2. By Dosage
      1. Introduction
        1. Dosage By Value
      2. High-dose Rate (HDR) Brachytherapy
        1. By Value
      3. Low-dose Rate (LDR) Brachytherapy
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Seeds
        1. By Value
      3. Applicators & Afterloaders
        1. By Value
      4. Electronic Brachytherapy
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Prostate Cancer
        1. By Value
      3. Gynecological Cancer
        1. By Value
      4. Breast Cancer
        1. By Value
      5. Others
        1. By Value
    5. U.K.
      1. By Dosage
        1. Introduction
          1. Dosage By Value
        2. High-dose Rate (HDR) Brachytherapy
          1. By Value
        3. Low-dose Rate (LDR) Brachytherapy
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Seeds
          1. By Value
        3. Applicators & Afterloaders
          1. By Value
        4. Electronic Brachytherapy
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Prostate Cancer
          1. By Value
        3. Gynecological Cancer
          1. By Value
        4. Breast Cancer
          1. By Value
        5. Others
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Dosage
      1. Introduction
        1. Dosage By Value
      2. High-dose Rate (HDR) Brachytherapy
        1. By Value
      3. Low-dose Rate (LDR) Brachytherapy
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Seeds
        1. By Value
      3. Applicators & Afterloaders
        1. By Value
      4. Electronic Brachytherapy
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Prostate Cancer
        1. By Value
      3. Gynecological Cancer
        1. By Value
      4. Breast Cancer
        1. By Value
      5. Others
        1. By Value
    5. China
      1. By Dosage
        1. Introduction
          1. Dosage By Value
        2. High-dose Rate (HDR) Brachytherapy
          1. By Value
        3. Low-dose Rate (LDR) Brachytherapy
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Seeds
          1. By Value
        3. Applicators & Afterloaders
          1. By Value
        4. Electronic Brachytherapy
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Prostate Cancer
          1. By Value
        3. Gynecological Cancer
          1. By Value
        4. Breast Cancer
          1. By Value
        5. Others
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Singapore
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Dosage
      1. Introduction
        1. Dosage By Value
      2. High-dose Rate (HDR) Brachytherapy
        1. By Value
      3. Low-dose Rate (LDR) Brachytherapy
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Seeds
        1. By Value
      3. Applicators & Afterloaders
        1. By Value
      4. Electronic Brachytherapy
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Prostate Cancer
        1. By Value
      3. Gynecological Cancer
        1. By Value
      4. Breast Cancer
        1. By Value
      5. Others
        1. By Value
    5. UAE
      1. By Dosage
        1. Introduction
          1. Dosage By Value
        2. High-dose Rate (HDR) Brachytherapy
          1. By Value
        3. Low-dose Rate (LDR) Brachytherapy
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Seeds
          1. By Value
        3. Applicators & Afterloaders
          1. By Value
        4. Electronic Brachytherapy
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Prostate Cancer
          1. By Value
        3. Gynecological Cancer
          1. By Value
        4. Breast Cancer
          1. By Value
        5. Others
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Dosage
      1. Introduction
        1. Dosage By Value
      2. High-dose Rate (HDR) Brachytherapy
        1. By Value
      3. Low-dose Rate (LDR) Brachytherapy
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Seeds
        1. By Value
      3. Applicators & Afterloaders
        1. By Value
      4. Electronic Brachytherapy
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Prostate Cancer
        1. By Value
      3. Gynecological Cancer
        1. By Value
      4. Breast Cancer
        1. By Value
      5. Others
        1. By Value
    5. Brazil
      1. By Dosage
        1. Introduction
          1. Dosage By Value
        2. High-dose Rate (HDR) Brachytherapy
          1. By Value
        3. Low-dose Rate (LDR) Brachytherapy
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Seeds
          1. By Value
        3. Applicators & Afterloaders
          1. By Value
        4. Electronic Brachytherapy
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Prostate Cancer
          1. By Value
        3. Gynecological Cancer
          1. By Value
        4. Breast Cancer
          1. By Value
        5. Others
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Brachytherapy Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Varian Medical Systems Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Becton
    3. Dickinson & Company
    4. CIVCO Medical Solutions
    5. Elekta AB
    6. Isoray Medical Inc
    7. Eckert & Ziegler BEBIG
    8. iCAD Inc
    9. Theragenics Corporation
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Market Overview The global chemotherapy market size was valued at USD 9.5 billion in 2022. It is projected to reach USD 17.61 billion by 2031, growing at a CAGR of 7.1% during the forecast period (2023–2031). One or more chemotherap
Buy Now
Global Report
The global cryotherapy market size was valued at USD 6.36 billion in 2021 and is projected to reach USD 11.85 billion by 2030, registering a CAGR of 7.16% from 2022 to 2030. Cryotherapy, also known as cold treatment or icepack therapy, is used to de
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.